Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Venzon

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|July 1, 1991
Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsisH R Alexander, B C Sheppard, J C Jensen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2005
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]I Magrath, V Shanta, S Advani, et al.
Blood|March 25, 2000
Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected menT L Lehrnbecher, C B Foster, S Zhu, et al.
Blood|March 15, 1996
Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancerJ A O'Shaughnessy, A Tolcher, D Riseberg, et al.
Journal of Virology|February 23, 2000
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challengeA Seth, I Ourmanov, J E Schmitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicinL H Wexler, M P Andrich, D Venzon, et al.
Nature Medicine|October 4, 2000
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaquesZ Hel, D Venzon, M Poudyal, et al.
Mucosal Immunology|December 17, 2008
CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infectionM Vaccari, A Boasso, Z-M Ma, et al.
Nature Medicine|November 2, 2001
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopesX Chen, G Scala, I Quinto, et al.
The Journal of Infectious Diseases|July 1, 1996
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working GroupL L Lewis, D Venzon, J Church, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|July 1, 1991
Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsisH R Alexander, B C Sheppard, J C Jensen, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2005
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected]I Magrath, V Shanta, S Advani, et al.
Blood|March 25, 2000
Variant genotypes of FcgammaRIIIA influence the development of Kaposi's sarcoma in HIV-infected menT L Lehrnbecher, C B Foster, S Zhu, et al.
Blood|March 15, 1996
Prospective, randomized trial of 5-fluorouracil, leucovorin, doxorubicin, and cyclophosphamide chemotherapy in combination with the interleukin-3/granulocyte-macrophage colony-stimulating factor (GM-CSF) fusion protein (PIXY321) versus GM-CSF in patients with advanced breast cancerJ A O'Shaughnessy, A Tolcher, D Riseberg, et al.
Journal of Virology|February 23, 2000
Immunization with a modified vaccinia virus expressing simian immunodeficiency virus (SIV) Gag-Pol primes for an anamnestic Gag-specific cytotoxic T-lymphocyte response and is associated with reduction of viremia after SIV challengeA Seth, I Ourmanov, J E Schmitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicinL H Wexler, M P Andrich, D Venzon, et al.
Nature Medicine|October 4, 2000
Viremia control following antiretroviral treatment and therapeutic immunization during primary SIV251 infection of macaquesZ Hel, D Venzon, M Poudyal, et al.
Mucosal Immunology|December 17, 2008
CD4+ T-cell loss and delayed expression of modulators of immune responses at mucosal sites of vaccinated macaques following SIV(mac251) infectionM Vaccari, A Boasso, Z-M Ma, et al.
Nature Medicine|November 2, 2001
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopesX Chen, G Scala, I Quinto, et al.
The Journal of Infectious Diseases|July 1, 1996
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working GroupL L Lewis, D Venzon, J Church, et al.
Pageof 11